Dalbavancin is a novel antimicrobial against Gram-positive pathogens: Clinical experience beyond labelled indications

  1. Núñez-Núñez, M.
  2. Casas-Hidalgo, I.
  3. García-Fumero, R.
  4. Vallejo-Rodríguez, I.
  5. Anguita-Santos, F.
  6. Hernández-Quero, J.
  7. Cabeza-Barrera, J.
  8. Ruiz-Sancho, A.
Journal:
European Journal of Hospital Pharmacy

ISSN: 2047-9964,  2047-9956

Year of publication: 2020

Volume: 27

Issue: 5

Pages: 310-312

Type: Article

DOI: 10.1136/EJHPHARM-2018-001711 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus